30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Biologica Technologies Presents Update on ProteiOS Growth Factor -

Biologica Technologies is debuting initial clinical data from spinal applications using its ProteiOS® growth factor derived from minimally manipulated allogeneic bone marrow. ProteiOS comprises angiogenic, mitogenic and osteoinductive proteins and what is reportedly the highest amount of non-recombinant BMP-2, and is designed for use with a surgeon's preferred FDA-cleared scaffold. ProteiOS entered limited launch in 4Q17, and is now available throughout the U.S. (Biologica Technologies LLC, 4/30/18)